Background: Histamine is a major inflammatory mediator. Results: H 1 receptor, STIM1, Orai1, and extracellular calcium are indispensable for histamine-induced intracellular calcium mobilization, NFAT nuclear translocation, and IL-8 production in HUVECs. Conclusion: STIM1 and Orai1 mediate histamine-evoked calcium entry and NFAT signaling in endothelial cells. Significance: STIM1 and Orai1 are essential for histamine-induced inflammatory signaling of endothelial cells.
Histamine is an important immunomodulator involved in allergic reactions and inflammatory responses. In endothelial cells, histamine induces Ca
2؉ mobilization by releasing Ca 2؉ from the endoplasmic reticulum and eliciting Ca 2؉ entry across the plasma membrane. Herein, we show that histamine-evoked Ca 2؉ entry in human umbilical vein endothelial cells (HUVECs) is sensitive to blockers of Ca 2؉ release-activated Ca 2؉ (CRAC) channels. RNA interference against STIM1 or Orai1, the activating subunit and the pore-forming subunit of CRAC channels, respectively, abolishes this histamine-evoked Ca 2؉ entry. Furthermore, overexpression of dominant-negative CRAC channel subunits inhibits while co-expression of both STIM1 and Orai1 enhances histamine-induced Ca 2؉ influx. Interestingly, gene silencing of STIM1 or Orai1 also interrupts the activation of calcineurin/nuclear factor of activated T-cells (NFAT) pathway and the production of interleukin 8 triggered by histamine in HUVECs. Collectively, these results suggest a central role of
STIM1 and Orai1 in mediating Ca
2؉ mobilization linked to inflammatory signaling of endothelial cells upon histamine stimulation.
Inflammation is a complex biological response to injury and infection; a protective attempt aimed to remove harmful stimuli and to initiate the healing process (1) (2) (3) . However, when inflammation becomes uncontrolled, it may turn into inflammatory disorders, leading to destruction of healthy tissues (3, 4) .
Histamine, a biogenic amine, is one of the major inflammatory mediators that can modulate vascular function (e.g. increased vascular leakage) during inflammation (5) (6) (7) (8) (9) . Released by mast cells or other leukocytes, histamine induces cytoskeletal reorganization in endothelial cells and intercellular gap formation, leading to endothelial hyperpermeability (9, 10) . Histamine also triggers leukocyte extravasation by promoting surface expression of P-selectin (6, 11) and production/secretion of interleukin 8 (IL-8) through calcineurin (12, 13) , a Ca 2ϩ -dependent phosphatase, in endothelial cells. Activation of calcineurin also contributes to the immune response, signaling by members of the nuclear factor of activated T-cells (NFAT) 5 family (14, 15) . The effects of histamine are mediated by four G-protein coupled receptors (GPCRs) -H 1 , H 2 , H 3 , and H 4 receptors (16, 17) . H 1 receptors are highly expressed in the endothelium and H 1 receptor antagonists suppress histamine-induced endothelial hyperpermeability (9, 18) . Histamine binding to H 1 receptors activates phospholipase C, which hydrolyzes phosphatidylinositol 4,5-bisphosphate to produce inositol trisphosphate (IP 3 ) and diacylglycerol (19) . IP 3 in turn triggers Ca 2ϩ release from the endoplasmic reticulum (ER) through IP 3 receptors; a key signaling event mediating various physiological and pathophysiological processes of the cell (20 -22) .
Store-operated Ca 2ϩ entry (SOCE) conducted through the Ca 2ϩ release-activated Ca 2ϩ (CRAC) channels in the plasma membrane (PM) is a key component of the cellular Ca 2ϩ signaling pathway (23) (24) (25) . Sustained activities of CRAC channels are essential for the activation of NFAT transcription factors in T lymphocytes, which leads to proper immune responses (25, 26) . However, it remains unclear whether CRAC channels are necessary for NFAT activation in endothelial cells. Orai1 and STIM1 have been identified and characterized as the poreforming subunit of CRAC channels and the ER Ca 2ϩ sensor for channel activation, respectively (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) . Upon Ca 2ϩ release from the ER, STIM1 oligomerizes and subsequently moves to the ER-PM junctions, binding to and activating Orai1 channels for Ca 2ϩ entry (28, 29, 33, 36 -41) . However, it has not been addressed whether this Ca 2ϩ entry pathway contributes to the Ca 2ϩ mobilization and function of vascular cells in response to histamine.
Recent in vitro studies indicate that both STIM1 and Orai1 are functionally expressed in endothelial cells, mediating SOCE for cell proliferation and migration (42) (43) (44) . It is also suggested, by animal studies, that STIM1 plays an essential role in coronary endothelial dysfunction associated with diabetes (45), lipopolysaccharide-induced vascular leakage and pulmonary edema (46) . However, the role of CRAC channels in the histamine-triggered inflammatory response has not been well examined. In the present study, utilizing both pharmacological and molecular tools specific to CRAC channels, we elucidated the contribution of STIM1 and Orai1 to histamine-evoked intracellular Ca 2ϩ mobilization and downstream cytokine production in endothelial cells.
EXPERIMENTAL PROCEDURES
Chemicals-Histamine, gelatin solution (2%), diphenhydramine hydrochloride, fexofenadine hydrochloride, and GdCl 3 were purchased from Sigma. Thapsigargin, 2-aminoethyl diphenylborinate (2-APB), SKF-96365, and BTP2 were purchased from EMD. Cyclosporin A (CsA) was purchased from Alomone Labs.
Molecular Cloning-The generation of pcDNA3/humanSTIM1, eGFP-tagged wild-type (WT) humanOrai1, Orai1-E106A, and Orai1-R91W mutants was described previously (27, (47) (48) (49) . eGFP-NFATc1 was purchased from Addgene. The AdEasy system was used to create recombinant adenoviruses carrying eGFP-NFATc1 (50, 51) . Briefly, a 2.9 kb KpnI-EcoRV eGFPNFATc1 fragment was subcloned into the pShuttle-CMV vector. The resultant plasmids were linearized and transformed into competent BJ5183 Escherichia coli containing the adenoviral backbone plasmid pAdEasy-1 to generate kanamycin resistant, recombinant adenovirus plasmids, which were then transfected into HEK 293 cells for virus production. (49, 52) . HUVECs were incubated with 2 M Fura-2 AM in the culture medium at 37°C for 30 min. Transfected cells were identified by the presence of fused or coexpressed eGFP; using Semrock filters (BrightLine singleband multi-exciter filter set, optimized for Fura-2) to minimize contamination of Fura-2 fluorescence by bleed-through of eGFP fluorescence. Solution recipes are summarized in supplemental Table S1 . Data were analyzed with Metafluor software (Universal Imaging) and OriginPro 8 software (OriginLab) and are expressed as means Ϯ S.E. (supplemental Table S2 ).
RNA Interference (RNAi)-For each of STIM1, Orai1, Orai2, and Orai3, a mixture of four siRNAs was purchased from Dharmacon (47) . Control non-targeting siRNA was also obtained from Dharmacon. HUVECs were transfected by siRNAs using Lipofectamine RNAiMAX Transfection Reagent (Life Technologies).
RNA Isolation and Reverse Transcription Polymerase Chain Reaction (RT-PCR)-Total
RNA was isolated from HUVECs using RNeasy Mini Kit (Qiagen) following the manufacturer's protocol. The methods for RT-PCR were the same as described before (47) . Quantitative-PCRs were performed using RT 2 SYBR Green ROX qPCR Mastermix (Qiagen).
Fractionation and Western Blot-The separation and preparation of cytoplasmic and nuclear extracts from HUVECs were done with the NE-PER Nuclear and Cytoplasmic Extraction Reagents (ThermoFisher Scientific). Samples were resolved by SDS-PAGE and analyzed by standard Western blotting. Immunoblots were incubated with the primary antibodies indicated, including rabbit anti-STIM1 (1:1000) (27) , mouse anti-GAPDH (1:10,000, Fitzgerald clone 6C5), rabbit anti-Orai1 (1:500, Alomone Labs), rabbit anti-Orai2 (1:500, Alomone Labs), rabbit anti-Orai3 (1:500, Alomone Labs), mouse anti-HDAC1 (1:500, Upstate clone 2E10), mouse anti-␣-tubulin (1:500, ThermoFisher Scientific clone TU-01), and mouse anti-GFP-HRP (1:1000, Miltenyi Biotec).
Confocal Imaging-The methods for cell preparation were described previously (52) . Fixed cells were viewed under a confocal laser-scanning microscope (FV300; Olympus) equipped with FluoView software.
Enzyme-linked Immunosorbent Assay (ELISA)-Anti-interleukin 8 ELISA experiments were performed using Human CXCL8/IL-8 Quantikine ELISA Kit (R&D systems) following the manufacturer's protocol. (Ca2, see supplemental Table  S1 ), and histamine was applied at three different final concentrations (1, 10, and 100 M). As expected, the intracellular Ca (Fig. 1C ). To examine whether this histamine-evoked Ca 2ϩ mobilization involved Ca 2ϩ release from the ER, histamine was applied to the cells bathed in a solution without Ca 2ϩ (Ca0, see supplemental Table S1 ) to eliminate possible Ca 2ϩ entry. Under this condition, the initial [Ca 2ϩ ] i response was still elicited by histamine in a dose-dependent manner (Fig. 1, D-F -There are four H-subtype cell surface GPCRs that can mediate cellular response to histamine. Because H 1 receptors are functionally more dominant in endothelium (9), diphenhydramine (6, 21) , and fexofenadine (53, 54) , two specific H 1 receptor antagonists, were applied to evaluate whether H 1 receptors are responsible for the histamineevoked mobilization of intracellular Ca 2ϩ in HUVECs. As expected, 40 min preincubation with either diphenhydramine (30 M) or fexofenadine (30 M) prevented both histaminetriggered store release (Fig. 2, A, D , G, and J) and Ca 2ϩ entry (Fig. 2, B , E, H, and K). In contrast, both diphenhydramine and fexofenadine had no significant effect on the Ca 2ϩ entry induced by thapsigargin (TG, Fig. 2 , C, F, I, and L), a sarco/ endoplasmic reticulum Ca 2ϩ -ATPase (SERCA) pump inhibitor (55), which passively depletes Ca 2ϩ in the ER store in conjunction with triggering store-operated Ca 2ϩ entry via CRAC channels (Fig. 2C) Table S1) (29), 50 M 2-APB (56), 20 M SKF-96365 (57), and 10 M BTP2 (58) that have been shown to effectively block CRAC channels were independently applied. Each of these agents inhibited not only the TG-evoked Ca 2ϩ entry in HUVECs (Fig. 3 , A-F) but also, at the same concentrations, the histamine-evoked Ca 2ϩ entry (Fig. 3, G-L) . In another set of experiments, HUVECs were preincubated with 10 M Gd 3ϩ or 10 M BTP2 before the application of histamine. Consistently, the sustained component, but not the initial store release, of Ca 2ϩ mobilization by histamine was abolished (Fig. 4, A-D) . These results demonstrate that CRAC channels are responsible for conducting histamine-evoked Ca 2ϩ entry. However, the possible contribution of other Ca 2ϩ entry via Ca 2ϩ -permeable channels in the PM secondary to the CRAC channel activation cannot be ruled out in this set of studies.
RESULTS

Histamine
Inhibiting STIM1 Expression by RNA Interference Eliminates Histamine-evoked Ca 2ϩ Entry-It was reported that CRAC channels were formed by STIM1 and Orai1 in endothelial cells (42, 43) . To examine the role of STIM1 in histamine-evoked Ca 2ϩ entry, HUVECs were transfected with siRNA against STIM1 to disrupt the endogenous expression of STIM1. Cells treated with non-targeting siRNA were tested in parallel. While non-targeting siRNA did not significantly alter TG-induced Ca 2ϩ influx, compared with untreated cells (Fig. 5, A, B , and G), STIM1-siRNA treated cells showed very little SOCE upon TG stimulation (Fig. 5C ), indicating that STIM1 is necessary for CRAC channel functioning in HUVECs. Consistently, RNAi against STIM1 also prevented HUVECs from responding to histamine for intracellular Ca 2ϩ mobilization (Fig. 5, D-F and H) . The effect of RNAi on STIM1 expression was confirmed by RT-PCR (supplemental Fig. S1, A and B) and Western blot (Fig. 5I) .
Gene Silencing of Orai1, but Not Orai2 or Orai3, Hinders Ca 2ϩ Influx Triggered by Histamine-The involvement of three Orai channels (36) in histamine-evoked Ca 2ϩ entry was also tested in HUVECs using RNAi approach. In cells transfected with siRNA specifically targeting Orai1, TG and histamine failed to stimulate Ca 2ϩ influx (Fig. 6, A, B , E, and F). In contrast, knocking-down Orai2 or Orai3 did not reduce Ca 2ϩ influx in response to TG or histamine (Fig. 6, C, D, G, and H) . The specificity and efficacy of all the siRNA species on HUVECs were verified by RT-PCR (supplemental Fig. S1, C-F) . Several anti-Orai2 and anti-Orai3 antibodies were tested, but none of them could detect endogenous Orai2 and Orai3 proteins in HUVECs, respectively (Fig. 6I and supplemental Fig. S2 ). In 
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OCTOBER 17, 2014 • VOLUME 289 • NUMBER 42 contrast, these proteins were detected in the cells transfected with human Orai2 or Orai3 plasmids ( Fig. 6I and supplemental Fig. S2 ), indicating that Orai2 and Orai3 are not expressed or the expression levels are not detectable in HUVECs. Notably, endogenous Orai1 proteins were detected and the expression was effectively knocked down by Orai1 RNAi (Fig. 6I) . Our results indicate that Orai1 and STIM1, the pore-forming and activating subunits, respectively, form the main type of endothelial CRAC channels, downstream of H 1 receptors, mediating Ca 2ϩ mobilization upon histamine stimulation.
Overexpression of Dominant-negative Orai1 Mutants Suppresses Histamine-evoked Ca
2ϩ Entry-Dominant-negative Orai1 mutants were employed to suppress the activity of endogenous Orai1 channels. The Orai1-E106A mutant (33, 34, 48) and Orai1-R91W mutant (30, 49, 59) , with altered selectivity filter and inner gate of the channel pore, respectively, have been shown to disrupt channel function. The corresponding eGFP-fused cDNA constructs were delivered into HUVECs via nucleofection. Cells expressing either eGFP-Orai1-E106A or eGFP-Orai1-R91W led to diminished Ca 2ϩ influx in response to TG (Fig. 7, A-D) as well as histamine (Fig. 7, E-H) , emphasizing the indispensable role of Orai1 in histamine-evoked Ca 2ϩ influx. 
Histamine-evoked Ca 2ϩ Entry Is Amplified by Overexpression of Both STIM1
and Orai1-The role of STIM1 and Orai1 in mediating histamine-evoked Ca 2ϩ entry was further tested by overexpressing both channel molecules, STIM1 and eGFPtagged Orai1, in HUVECs. Control cells were transfected with eGFP alone. As expected, co-expression of STIM1 and Orai1 significantly increased Ca 2ϩ influx induced by TG or histamine (Fig. 8) .
Histamine-evoked Ca 2ϩ Entry Causes Nuclear Import of NFAT-Members of the NFAT family are Ca 2ϩ
-sensitive transcription factors (14, 60) . After dephosphorylation by calcineurin, NFAT proteins translocate from the cytosol to the nucleus where they bind to promoter regions to turn on expression of numerous genes. However, the role of CRAC channels in mediating NFAT signaling in endothelial cells remains unclear, especially in relation to the inflammatory agent histamine. To OCTOBER 17, 2014 • VOLUME 289 • NUMBER 42 address this issue, the subcellular localization of NFATc1 was examined by confocal imaging of HUVECs transfected with eGFP-NFATc1. In control cells, the exogenous NFATc1 molecules appeared to be distributed in the cytosol (Fig. 9, A and I ), which exhibited a low level of Ca 2ϩ (Fig. 1) . In contrast, in cells with 100 M histamine for 15-30 min in the presence of 2 mM extracellular Ca 2ϩ , eGFP-NFATc1 translocated to the cell nuclei (Fig. 9, B and J) . This nuclear translocation process was blocked by H 1 receptor antagonist (Fig. 9C) . These results suggest a pivotal role of Ca 2ϩ elevation, via extracellular Ca 2ϩ entry (Fig. 9D) , in mediating the NFAT nuclear translocation following H 1 receptor activation by histamine. Moreover, the nuclear translocation of eGFP-NFATc1 is sensitive to both cyclosporin A (Fig. 9E) , a calcineurin inhibitor (61) , and Gd 3ϩ (Fig. 9F) , a CRAC channel blocker. These data support the idea that Ca 2ϩ entry through CRAC channels activates calcineurin for NFATc1 dephosphorylation and subsequently leads to the nuclear import. Knocking-down STIM1 or Orai1 in HUVECs also prevented histamine-induced NFAT nuclear translocation (Fig. 9, G-H and K-L) , further supporting a role of CRAC channel in regulating gene expression through the calcineurin-NFAT pathway. In parallel, fractionation experiments were performed to demonstrate nuclear import of NFAT transcription factors. An adenovirus vector carrying eGFP-NFATc1 was initially created to identify exogenous NFAT expression in HUVECs. Confocal imaging results confirmed a histamine-induced nuclear import of eGFP-NFATc1 in HUVECs transduced by the Ad-eGFP-NFATc1 viruses (data not shown). Next, the cytoplasmic and nuclear components were extracted from total HUVEC lysates and HDAC1 and alpha-tubulin were stained as nuclear and cytoplasmic markers, respectively. In consistence with the confocal imaging data, histamine (100 M) , STIM1-siRNA, or Orai1-siRNA (Fig. 10) . STIM1 and Orai1 Are Indispensable for Histamine-promoted Interleukin 8 Expression-Interleukin 8, a chemokine produced by macrophages and endothelial cells, is essential for leukocyte chemoattraction and phagocytosis during inflammation (62, 63) . The production of IL-8 in endothelial cells has been suggested to be enhanced by histamine in a calcineurin-dependent manner (12, 13) . To determine whether functional CRAC channels are central to the regulation of IL-8 expression, the IL-8 mRNA level was measured by RT-PCR. Incubating HUVECs with 100 M histamine for one hour significantly up-regulated IL-8 mRNA in a manner sensitive to cyclosporin A (1 M, Fig.  11A ). More importantly, the histamine-promoted IL-8 expression was also abolished by RNAi against Orai1 or STIM1 (Fig.   11A ). Moreover, 24-hour treatment of HUVECs with 100 M histamine led to a more than 3-fold increase in IL-8 production/secretion from these cells (Fig. 11B) . This response was blocked by treating the cells with cyclosporin A (1 M) or siRNA against Orai1 or STIM1 (Fig. 11B) , indicating the close link between calcineurindependent signaling and CRAC channel activation for IL-8 synthesis/release in HUVECs upon histamine stimulation.
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DISCUSSION
Inflammation is the bodies primary immune response to injury and infection; however, unregulated inflammation would cause damage to healthy tissues (2) (3) (4) . Inflammatory disorders are considered to be one of the major pathogenic factors that cause a wide variety of human diseases, including but not limited to asthma, atherosclerosis, autoimmune diseases, inflammatory bowel diseases, reperfusion injury, and rheumatoid arthritis (2, 4, 64, 65 ). OCTOBER 17, 2014 • VOLUME 289 • NUMBER 42
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Histamine is an important inflammatory mediator that has been commonly targeted to alleviate allergies and inflammatory responses (66, 67) . In this study, we have demonstrated that the CRAC channel, formed by STIM1 and Orai1, mediates the histamine-evoked Ca 2ϩ entry and the downstream NFAT nuclear translocation, as well as cytokine production, in HUVECs. These results suggest a unique role for CRAC channels in endothelium and its potential contribution to the development of inflammatory response.
Accumulating evidence on the Ca 2ϩ entry through storeoperated channels (e.g. CRAC channels) following depletion of the intracellular Ca 2ϩ -store suggests a ubiquitous and essential homeostatic signaling mechanism in immune cells (23, 25, 26, 36) . Using pharmacological tools in combination with ratiometric Ca 2ϩ imaging approach, we have elucidated that the intracellular Ca 2ϩ mobilization in response to histamine involves H 1 receptor-dependent store release followed by a sustained extracellular Ca 2ϩ influx through CRAC channels in vascular endothelial cells (Figs. 1-4) . This observation indicates that histamine-initiated vascular response in inflammation is partially due to the activation of CRAC channels.
In the current study, for the first time, we applied molecular tools at the gene level to determine the contribution of CRAC channels in mediating the histamine-elicited biological response in HUVECs. The human genome contains two STIM (STIM1 and STIM2) and three Orai (Orai1, Orai2, and Orai3) genes (36) . Genetic defects in both STIM1 and Orai1 have been shown to cause immunodeficiency and autoimmunity in human patients (30, 68 -70) . Our results from the RNAi study demonstrated that STIM1 is indispensable for histamineevoked Ca 2ϩ entry in HUVECs (Fig. 5) . It has been suggested that STIM2 may be functionally different from STIM1, that it is probably involved in the regulation of basal cytosolic Ca 2ϩ level (71) . Although it was not tested in the present study, the role of STIM2 in modulating intracellular Ca 2ϩ level during histamine stimulation deserves future investigation. It is worth noting that the biophysical properties of ionic currents mediated by Orai2 and Orai3 channels have been shown to be very close to that of Orai1 channels (47, (72) (73) (74) . However, our RNAi data indicate that Orai1, but not Orai2 or Orai3, is critical in mediating the histamineevoked Ca 2ϩ entry (Fig. 6 ). The necessity of CRAC/Orai1 channels to conduct Ca 2ϩ influx in response to histamine was further confirmed by the reversed Ca 2ϩ phenotypes following overexpression of wild-type versus dominant-negative Orai1 mutants (Figs. 7 and  8 ). The designation that specific Orai channels are linked to the activation of corresponding receptors might be important for the selective activation of a biological function in association with Ca 2ϩ mobilization in the biological system. Leukocytes are critical for the initiation and maintenance of inflammation (65) . Leukocyte extravasation is a process of cell migration from the blood to the injured tissue across the vascular wall, including the steps of chemoattraction, rolling adhesion, tight adhesion, and transmigration (75, 76) . It has been indicated that leukocyte recruitment can be interrupted when any of these steps is suppressed. IL-8 is a chemoattractant that directs neutrophils and other granulocytes to migrate toward the site of injury or infection, and anti-IL-8 therapy has been initiated for the treatment of inflammatory disorders (62, 63, 77) . IL-8 production in endothelial cells has been reported to be up-regulated through the calcineurin/NFAT pathway upon histamine stimulation (12, 13) . Our results suggest that extracellular Ca 2ϩ entry, via Orai1/STIM1 activation, is essential for the nuclear translocation of NFAT and IL-8 synthesis in response to histamine (Figs. 9, 10, and 11) . Thus, the CRAC channel may be a useful target for the control of leukocyte extravasation by modulating IL-8 synthesis in the endothelium. In summary, the current study elucidates the fundamental role of STIM1 and Orai1 in the signaling cascade initiated by histamine (Fig. 12 ). This is a critical step in the development of the inflammatory pathologies associated with numerous disease processes. Understanding the functional mechanisms of CRAC channels in inflammation could lead to the development of CRAC channel blockers as potential therapeutic tools for treating inflammatory disorders.
